BASKHANBIOPharma Inc. Logo

BASKHANBIOPharma Inc.

354390 | KO

Overview

Corporate Details

ISIN(s):
KR7354390007
LEI:
Country:
South Korea
Address:
경기도 안성시 원곡면 원당로 354, 안성시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

No description available.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-01 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-06-25 00:00
Report Publication Announcement
기업설명회(IR)개최결과
Korean 6.6 KB
2025-06-10 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.0 KB
2025-03-31 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 134.8 KB
2025-03-27 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 10.3 KB
2025-03-26 00:00
AGM Information
정기주주총회결과
Korean 23.9 KB
2025-03-18 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 375.9 KB
2025-03-11 00:00
Audit Report / Information
감사보고서제출
Korean 9.6 KB
2025-03-11 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 101.6 KB
2025-02-19 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 14.4 KB
2024-12-12 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.4 KB
2024-12-05 00:00
AGM Information
임시주주총회결과
Korean 5.4 KB
2024-11-20 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 38.7 KB
2024-11-13 00:00
Regulatory Filings
기업설명회(IR)개최결과
Korean 6.6 KB
2024-10-29 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.0 KB

Automate Your Workflow. Get a real-time feed of all BASKHANBIOPharma Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BASKHANBIOPharma Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BASKHANBIOPharma Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Emergent BioSolutions Inc. Logo
Develops and manufactures medical countermeasures for public health and national security threats.
United States of America
EBS
ENANTA PHARMACEUTICALS INC Logo
Developing novel small molecule drugs for virology (HCV, RSV) and immunological diseases.
United States of America
ENTA
Enervit Logo
Produces sports nutrition & wellness supplements for athletes and active lifestyles.
Italy
ENV
enGene Holdings Inc. Logo
Developing non-viral, locally administered gene therapies for rare genetic conditions.
United States of America
ENGN
Enliven Therapeutics, Inc. Logo
A clinical-stage biopharma developing kinase inhibitors for precision oncology cancer treatment.
United States of America
ELVN
Enlivex Therapeutics Ltd. Logo
Developing cell therapy to restore immune balance for inflammatory diseases like sepsis.
Israel
ENLV
Enlivex Therapeutics Ltd. Logo
Developing cell therapy that reprograms macrophages to treat immune hyper-responses like sepsis.
United States of America
ENLV
Enorama Pharma AB Logo
Develops & makes consumer nicotine products & medicated gums, offering private label solutions.
Sweden
ERMA
Ensol Biosciences Inc. Logo
Develops AI-discovered peptide drugs for cancer, osteoarthritis, and Alzheimer's disease.
South Korea
140610
Entera Bio Ltd. Logo
Developing oral versions of injectable drugs for osteoporosis, hypoparathyroidism, and obesity.
United States of America
ENTX

Talk to a Data Expert

Have a question? We'll get back to you promptly.